SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-21-122030
Filing Date
2021-10-01
Accepted
2021-10-01 16:42:04
Documents
13

Document Format Files

Seq Description Document Type Size
1 S-3 tm2128769-1_s3.htm S-3 595593
2 EXHIBIT 1.2 tm2128769d2_ex1-2.htm EX-1.2 233644
3 EXHIBIT 4.4 tm2128769d2_ex4-4.htm EX-4.4 266654
4 EXHIBIT 4.5 tm2128769d2_ex4-5.htm EX-4.5 298811
5 EXHIBIT 5.1 tm2128769d2_ex5-1.htm EX-5.1 42720
6 EXHIBIT 5.2 tm2128769d2_ex5-2.htm EX-5.2 11840
7 EXHIBIT 23.1 tm2128769d2_ex23-1.htm EX-23.1 2188
8 GRAPHIC lg_immunomereg-4clr.jpg GRAPHIC 22551
9 GRAPHIC lg_immunome-4clr.jpg GRAPHIC 17487
10 GRAPHIC tm2128769d1_ex5-1img003.jpg GRAPHIC 2609
11 GRAPHIC tm2128769d1_ex5-1imag006.jpg GRAPHIC 3784
12 GRAPHIC tm2128769d1_ex5-2imag001.jpg GRAPHIC 7789
13 GRAPHIC tm2128769d1_ex5-2imag002.jpg GRAPHIC 2261
  Complete submission text file 0001104659-21-122030.txt   1531196
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-259966 | Film No.: 211299470
SIC: 2834 Pharmaceutical Preparations